HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Glassy cell carcinoma of the cervix

Also Known As:

Glassy cell adenocarcinoma of the uterine cervix

Networked: 7 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Disease Context: Research Results

Neoplasms: 1324753
- Neoplasms by Site: 4
  - Urogenital Neoplasms: 471
    - Female Genital Neoplasms: 105
      - Uterine Neoplasms: 1516
        Uterine Cervical Neoplasms: 30061
        Glassy cell carcinoma of the cervix: 7
Urogenital Diseases: 126

Related Diseases

1.	Adenosquamous Carcinoma
2.	Neoplasm Metastasis (Metastasis)
3.	Cicatrix (Scar)

Experts

1.	Carocha, Ana Isabel: 1 article (04/2015)
2.	Correia, Lúcia: 1 article (04/2015)
3.	Gomes, António: 1 article (04/2015)
4.	Jorge, Ana Francisca: 1 article (04/2015)
5.	Pedroso, Célia: 1 article (04/2015)
6.	Hanami, Kyota: 1 article (07/2006)
7.	Itoyama, Shinji: 1 article (07/2006)
8.	Kuroda, Hajime: 1 article (07/2006)
9.	Kyoko, Kiuchi: 1 article (07/2006)
10.	Masuda, Tomoko: 1 article (07/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Glassy cell carcinoma of the cervix:

1.	Progesterone Receptors (Progesterone Receptor)IBA 01/01/1998 - "Absence of estrogen and progesterone receptors in glassy cell carcinoma of the cervix." 01/01/1998 - "To evaluate the estrogen and progesterone receptor status of glassy cell carcinoma of the cervix to assess the possible implications of hormone replacement therapy in these patients. " 07/01/2006 - "Glassy cell carcinoma of the cervix: cytologic features and expression of estrogen receptor, progesterone receptor and Her2/neu protein."
2.	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/01/2000 - "Response of glassy-cell carcinoma of the cervix to cisplatin, epirubicin, and mitomycin C."
3.	Epirubicin (Ellence)FDA LinkGeneric 04/01/2000 - "Response of glassy-cell carcinoma of the cervix to cisplatin, epirubicin, and mitomycin C."
4.	Estrogen ReceptorsIBA 07/01/2006 - "Glassy cell carcinoma of the cervix: cytologic features and expression of estrogen receptor, progesterone receptor and Her2/neu protein."
5.	Proteins (Proteins, Gene)FDA Link 07/01/2006 - "Glassy cell carcinoma of the cervix: cytologic features and expression of estrogen receptor, progesterone receptor and Her2/neu protein."
6.	Estrogens (Estrogen)FDA Link 01/01/1998 - "Absence of estrogen and progesterone receptors in glassy cell carcinoma of the cervix." 01/01/1998 - "To evaluate the estrogen and progesterone receptor status of glassy cell carcinoma of the cervix to assess the possible implications of hormone replacement therapy in these patients. "
7.	Cisplatin (Platino)FDA LinkGeneric 04/01/2000 - "Response of glassy-cell carcinoma of the cervix to cisplatin, epirubicin, and mitomycin C."

Therapies and Procedures

1.	Radiotherapy 03/01/1992 - "Survival of patients with Stage II glassy cell carcinoma of the cervix improved from 50% to 85% with combined radical surgery and radiotherapy. "
2.	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/01/1998 - "To evaluate the estrogen and progesterone receptor status of glassy cell carcinoma of the cervix to assess the possible implications of hormone replacement therapy in these patients. "
3.	Therapeutics 06/01/1988 - "Glassy cell carcinoma of the cervix has been classically regarded as a poorly differentiated adenosquamous carcinoma, infrequently diagnosed and associated with a poor outcome regardless of the modality of therapy. "
4.	Hysterectomy 06/01/1991 - "The aggressive course of a glassy cell carcinoma of the cervix in Stage Ib (FIGO) of a 24-year-old woman could neither be markedly influenced by radical hysterectomy, nor by chemotherapy and radiation. "
5.	Episiotomy 04/01/2015 - "The histologic diagnosis revealed a glassy cell carcinoma of the cervix, with metastasis in the episiotomy scar. " 04/01/2015 - "Glassy cell carcinoma of the cervix and metastasis in episiotomy scar: a case report."